Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
171.1 SEK | -1.72% | -2.23% | +27.97% |
Apr. 25 | Transcript : Biotage AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 25 | Biotage AB Approves a Dividend, Payable on May 3, 2024 | CI |
Sales 2024 * | 2.13B 203M | Sales 2025 * | 2.39B 228M | Capitalization | 13.69B 1.31B |
---|---|---|---|---|---|
Net income 2024 * | 265M 25.27M | Net income 2025 * | 357M 34.04M | EV / Sales 2024 * | 6.21 x |
Net cash position 2024 * | 473M 45.1M | Net cash position 2025 * | 780M 74.33M | EV / Sales 2025 * | 5.41 x |
P/E ratio 2024 * |
51.9
x | P/E ratio 2025 * |
38.5
x | Employees | 669 |
Yield 2024 * |
1.01% | Yield 2025 * |
1.23% | Free-Float | 99.55% |
Latest transcript on Biotage AB
1 day | -1.72% | ||
1 week | -2.23% | ||
Current month | -7.71% | ||
1 month | +0.65% | ||
3 months | -7.11% | ||
6 months | +40.82% | ||
Current year | +27.97% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 72 | 06-02-08 | |
Andrew Kellett
DFI | Director of Finance/CFO | 56 | 23-09-24 |
Chief Tech/Sci/R&D Officer | 54 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 72 | 06-02-08 | |
Åsa Hedin
BRD | Director/Board Member | 62 | 19-10-31 |
Kieran Murphy
CHM | Chairman | 61 | Jan. 03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 775 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-11 | 171.1 | -1.72% | 41,471 |
24-06-10 | 174.1 | -0.97% | 31,796 |
24-06-07 | 175.8 | +1.21% | 40,899 |
24-06-05 | 173.7 | -0.74% | 98,814 |
24-06-04 | 175 | -5.86% | 97,189 |
Delayed Quote Nasdaq Stockholm, June 11, 2024 at 12:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.97% | 1.3B | |
-25.12% | 16.69B | |
-45.71% | 2.68B | |
+24.57% | 1.97B | |
-10.64% | 1.49B | |
-14.14% | 989M | |
+4.20% | 807M | |
-29.96% | 801M | |
-24.44% | 633M | |
+20.28% | 578M |
- Stock Market
- Equities
- BIOT Stock